Leal Therapeutics
Develops neuro-metabolic therapeutics for schizophrenia and ALS
$30MSeries A
Role not disclosedAV
Alexandria Venture Investments
Activity from announced rounds
Activity in this selectionporsche-se-37ef5933
- Rounds participated in
- 10
- Confirmed lead rounds
- — 10 roles undisclosed
- New companies
- 10 First participation on record · 0 follow-on
- Funding in participating rounds
- $635M 10 disclosed · full round size, not this investor’s share
By stage
By primary sector
By country
Rounds
10 in this selectionKhartis Therapeutics
Develops oral small molecule therapies for immunological and chronic diseases
$50MSeries B
Role not disclosedVedana Therapeutics
Develops next-generation therapies for migraine prevention
$46MSeries A
Role not disclosedSonoThera
Develops ultrasound-mediated nonviral genetic medicines
$125MSeries B
Role not disclosedCREATE Medicines
Develops in vivo immune programming platform for scalable, repeat-dose immunotherapies
$122MSeries B
Role not disclosedFathom Therapeutics
Uses quantum chemistry and AI to design novel drug molecules
$47MSeries A
Role not disclosedAlloy Therapeutics
Drug discovery platforms and integrated development services for biotechnology and pharmaceutical partners.
$40MSeries E
Role not disclosedTen63 Therapeutics
Develops AI-driven drug discovery platform for first- and best-in-class therapeutics
$45MStrategic
Role not disclosedTRex Bio
Develops precision immunoregulatory medicines based on tissue Treg biology
$50MUndisclosed
Role not disclosedProxima
Develops AI-driven drug discovery for proximity therapeutics
$80MUndisclosed
Role not disclosed